USPTO serial 79129531
AXINON
Reviewed by CopyMark Law Group
Reg. 4582191Status 706Registered
- Filing date
- Status date
- Registration date
- Aug 12, 2014
- Examiner
- DAHLING, KRISTIN M
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with AXINON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nathan J. Prepelka, Registration No. 43,016
Nathan J. Prepelka, Registration No. 43,016 The Webb Law Firm420 Ft. Duquesne Blvd., Suite 1200One Gateway CenterPittsburgh, PA 15222Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; chemical preparations, namely, control solutions, diluents, calibrating substances, reference substances, and concentration markers for analyses of body fluids and their metabolites, and for analysis of plant extracts and extracts of fermentation processes in laboratories, other than for medical or veterinary purposes; chemical reagents other than for medical or veterinary purposes; biological preparations for use in analytic processes and for use in the identification and quantification of ingredients of chemical and biological compositions, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; assortments, namely, kits of chemicals for use in industry and science for analyses of body fluids and their metabolites, of plant extracts and extracts of fermentation processes, and for the identification and quantification of ingredients of chemical and biological compositions; none of the aforementioned goods relating to androgen replacement or testosterone replacement | ACTIVE | — |
| 005 | Chemicals in the nature of diagnostic preparations for medical and veterinary analyses in laboratories; none of the aforementioned goods relating to androgen replacement or testosterone replacement | ACTIVE | — |
| 009 | Scientific apparatus and instruments, namely, centrifuges, glass tubes, nuclear magnetic instruments in the nature of nuclear magnetic spectrometers and pipettors; scientific apparatus and instruments in the nature of automatic pipetting systems comprised of robotics for moving a sample, robotics for moving NMR tubes, and means for housing containers containing any of reagents, control substances, and calibrating substances; measuring apparatus and instruments, namely, nuclear magnetic instruments in the nature of nuclear magnetic spectrometers; testing apparatus not for medical purposes, namely, nuclear magnetic instruments in the nature of nuclear magnetic spectrometers; food analysis apparatus, namely, nuclear magnetic instruments in the nature of nuclear magnetic spectrometers; diagnosis apparatus, not for medical purposes, namely, nuclear magnetic instruments in the nature of nuclear magnetic spectrometers; laboratory equipment, namely, spectroscopes; recorded computer software, namely, analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, and software for controlling spectroscopes and nuclear magnetic instruments in the nature of nuclear magnetic spectrometers; downloadable computer programs featuring analytical software to obtain results from raw data, interface software for establishing connections to laboratory software and laboratory instrumentation, software for managing workflow processes, software for database management, and software for controlling spectroscopes and nuclear magnetic instruments in the nature of nuclear magnetic spectrometers; none of the aforementioned goods relating to androgen replacement or testosterone replacement | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the fields of spectroscopy, of analyses of body fluids and their metabolites, of plant extracts and extracts of fermentation processes, of identification and quantification of ingredients of chemical or biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes; industrial analysis and research services in the fields of spectroscopy, of analyses of body fluids and their metabolites, of plant extracts and extracts of fermentation processes, of identification and quantification of ingredients of chemical and biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes; computer hardware and software design and development; biological research; computer programming; installation and maintenance of computer software; updating of computer software; rental of computer software; measurement services, namely, performing measurements for third parties in the fields of spectroscopy, of analyses of body fluids and their metabolites, of plant extracts and extracts of fermentation processes, of identification and quantification of ingredients of chemical and biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes; research and analysis services in the fields of molecular biology, biochemistry and spectroscopy; research and development services in the fields of molecular biology, biochemistry and spectroscopy; scientific research in the fields of molecular biology, biochemistry and spectroscopy; services of medical and bacteriological research laboratories, namely, medical research and bacteriological research; services of chemical laboratories in the fields of spectroscopy, of analyses of body fluids and their metabolites, of plant extracts and extracts of fermentation processes, of identification and quantification of ingredients of chemical and biological compositions, of monitoring metabolic processes, of diagnosing metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes, and of monitoring the treatment of metabolic disorders, cardiovascular disorders, cancer, dementia and diabetes; none of the aforementioned services relating to androgen replacement or testosterone replacement | ACTIVE | — |
| 045 | Licensing of computer software in the nature of legal services; licensing of intellectual property rights, namely, industrial property rights and copyright; licensing of research methods; none of the aforementioned services relating to androgen replacement or testosterone replacement | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by numares AG
- Other trademarks owned by Numares GmbH
- Other trademarks owned by Numares GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named AXINON
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 10, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 10, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Feb 9, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 9, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 12, 2023 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Feb 17, 2023 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Dec 31, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 12, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 28, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 9, 2020 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Dec 9, 2020 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Dec 7, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 12, 2020 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Oct 9, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 12, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 19, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 18, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 13, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 26, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 26, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 12, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 13, 2014 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Aug 12, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 12, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 13, 2014 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| May 27, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 27, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 7, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 7, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 7, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 18, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 11, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 3, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 2, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 2, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2013 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2013 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 16, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 10, 2013 | ALIE | ASSIGNED TO LIE | — |
| Oct 8, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 7, 2013 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 7, 2013 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 24, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 28, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 28, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 28, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 26, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 25, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| May 23, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 22, 2013 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 16, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |